Research graph
References from Evaluating Precision and Responsiveness of MRI-derived Brain Volumetric and Clinical Outcome Measures in CLN3 Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1093/jnen/62.1.1
10.1093/jnen/62.1.1 · External reference
10.1007/s10048-005-0218-3
10.1007/s10048-005-0218-3 · External reference
10.1542/peds.44.4.570
10.1542/peds.44.4.570 · External reference
10.1186/s13023-025-04174-5
10.1186/s13023-025-04174-5 · External reference
Long-Term Open-Label Study Evaluating Oral Miglustat Treatment in Patients With Neuronal Ceroid Lipofuscinosis Type 3
10.1212/wnl.0000000000214110 · 2025 · External reference
Visual Recovery and Neurological Stabilization Following Miglustat Treatment in Pediatric CLN3 Disease
10.1177/08830738251374538 · 2026 · External reference
10.1523/jneurosci.2447-21.2023
10.1523/jneurosci.2447-21.2023 · External reference
Unresolved reference
External reference
10.1186/s40478-025-02059-z
10.1186/s40478-025-02059-z · External reference
10.1038/s41591-020-0986-1
10.1038/s41591-020-0986-1 · External reference
10.1093/nar/gkaf1141
10.1093/nar/gkaf1141 · External reference
10.1212/wnl.0b013e318237f649
10.1212/wnl.0b013e318237f649 · External reference
The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample
10.1016/j.ejpn.2022.03.005 · 2022 · External reference
10.1007/s10545-018-0143-x
10.1007/s10545-018-0143-x · External reference
Use of the Vineland-3, a measure of adaptive functioning, in CLN3
10.1002/ajmg.a.62607 · 2022 · External reference
10.1007/s00234-022-02988-9
10.1007/s00234-022-02988-9 · External reference
10.1016/j.pediatrneurol.2013.10.013
10.1016/j.pediatrneurol.2013.10.013 · External reference
Which Score for What?
2025 · External reference
10.1212/wnl.0000000000009454
10.1212/wnl.0000000000009454 · External reference
10.32614/r.manuals
10.32614/r.manuals · External reference
10.1097/prs.0000000000009188
10.1097/prs.0000000000009188 · External reference
10.1016/j.dcn.2018.03.001
10.1016/j.dcn.2018.03.001 · External reference
10.1186/s12888-016-0770-4
10.1186/s12888-016-0770-4 · External reference
Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative
10.1177/0271678x19888967 · 2020 · External reference
Cortical Thickness Estimation in Individuals With Cerebral Small Vessel Disease, Focal Atrophy, and Chronic Stroke Lesions
2020 · External reference
